An essential part of our mission is to develop human compatible organs to ensure there is no shortage of organs for those in need. We have a robust approach to developing human compatible organs that has been meticulously designed for safety, efficacy, and efficiency.
Single Cell Cloning
Somatic Cell Nuclear / Embryo Transfer
eGenesis is on the forefront of pioneering clinical studies for solid organ xenotransplantation. Our lead programs are for kidney and islet cell transplantation, which are both currently in preclinical development. eGenesis has a platform technology that allows for a broad pipeline of applications. We are actively investigating additional indications such as liver, heart, and lung as well as cell therapies.
We are a science-first team. To learn more, view our publications.